Moderna Inc. stock rises Tuesday, outperforms market

This post was originally published on this site

© Terrence Horan


Shares of Moderna Inc. MRNA advanced 3.27% to $183.41 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.01% to 33,984.93 and the NASDAQ Composite Index COMP falling 0.34% to 14,090.22. This was the stock’s third consecutive day of gains. Moderna Inc. closed $5.85 short of its 52-week high ($189.26), which the company achieved on February 8th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV rose 0.04% to $111.44, Amgen Inc. AMGN fell 0.15% to $255.13, and AstraZeneca PLC ADR AZN remained unchanged. Trading volume (12.9 M) eclipsed its 50-day average volume of 9.3 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading